Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q2 2022 call → NOWe need to determine if management conveys that outsiders are currently underweighting something the company has already done, and points to a concrete, already-completed/operating piece of the business whose contribution is still ahead. Let's analyze the transcript. Key points: - Revenue acceleration, customer growth, net retention rates up. - Dustin: "We are now at a $358 million GAAP revenue run-rate." "We are seeing record top of funnel volume, demand around the globe, and rapid expansions within our customer base." - Dustin: "The investments in our product strategy and the Work Graph are paying off, and this is just the beginning." - Dustin: "We build products that give clarity to individuals, teams and executives." Mentions Asana Partners, Universal Reporting, new languages, etc. - Dustin: "On October 20, at our enterprise event called Scale, we’ll be unveiling a suite of new features..." (future) - Dustin: "we remain on track to launch our entirely new take on workflows at the end of our fiscal year." (future) - Chris: "We continue to see record top of funnel growth." "We also completed the additional language rollout for the year and now have 13 languages in total." (already done) - Chris: "we are seeing our investments paying off in enterprise, driving continued enterprise momentum." "The number of customers spending $50,000 or more annually grew 111% to 598 in the quarter." (already done) - Chris: "IDC recently released an independent study of the business value of Asana" (already done) - Chris: "Last quarter, we shared our largest customer deployment expanded to 50,000 seats. This quarter, we saw another Fortune 50 company expand their deployment to more than 25,000 seats." (already done) - Chris: "We had some spectacular customer wins this quarter, including ViacomCBS, Fujitsu, Just Eat Takeaway, Cohesity." (already done) - Tim: "We are very proud of our achievements and the business momentum." "We are raising our full year guidance by 6% to a range of $357 million to $359 million." - Tim: "We expect non-GAAP operating margins to improve from fiscal year '21." Now, does management convey that outsiders are currently underweighting something the company has already done? Look for any statement about how the company is perceived, measured, or modeled.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.